Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma
Cisplatin is the commonly used chemotherapeutic drug in treatment of various cancers. However, development of resistance towards cisplatin results in tumor recurrence. Here, we aim to understand the mechanisms of action of cisplatin and emergence of resistance to cisplatin using mass spectrometry-ba...
Saved in:
| Main Authors: | Ankit P. Jain, Vivek Ghose, Srijon Munshi, Firdous A. Bhat, Gourav Dey, Vishalakshi Nanjappa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Molecular & Cellular Oncology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/23723556.2024.2328873 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Association of OLFM4 with the Progression and Cisplatin Resistance of Head and Neck Squamous Carcinoma
by: Xinlu He, et al.
Published: (2025-05-01) -
Characterization of high protein soybean using mass spectrometry based proteomic and metabolomic analyses
by: Nazrul Islam, et al.
Published: (2024-12-01) -
Protocol for dual metabolomics and proteomics using nanoflow liquid chromatography-tandem mass spectrometry
by: Weiwei Lin, et al.
Published: (2025-06-01) -
Mass spectrometry‐based proteomics for biomarker discovery in the Drosophila model of Parkinson's disease
by: Mohammad Radid Khan, et al.
Published: (2024-12-01) -
Optimizing imputation strategies for mass spectrometry-based proteomics considering intensity and missing value rates
by: Yuming Shi, et al.
Published: (2025-01-01)